CashuMedtronic Plans IDE Submission to FDA Following Clinical Trials in Brazil and Australia6 days ago
benzinga.comGlucoTrack Stock Gains As Data Backs FDA Filing Plans For Glucose Monitoring Tech8 days ago
cnbc.comMarket volatility has boosted dividend stocks. These are among Wolfe Research's favorites19 days ago
benzinga.comMedtronic's $550 Million Scientia Vascular Deal Aims To Boost Neurovascular Portfolio25 days ago
prnewswire.comMedtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care25 days ago